EW
Edwards Lifesciences
$88.83
▲ +3.21%
+$2.76
NYSE · Healthcare · Medical Devices
· price updated 9h ago
Edwards Lifesciences
EW · NYSE · Healthcare · Medical Devices · price updated 9h ago
$88.83
▲ +3.21% · +$2.76 today
AI research · $88.83
Track EW for continuous AI research
price position
Where EW sits now
52-week range
Low$72.30
High$96.29
Today $88.83
RSI (14)
46.2Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$3.7B
Total debt$702.9M
Net cash after debt$3.0B
Valuation
What the market charges
Forward P/E
Price against expected earnings
Needs attention · 51% above Sector avg
27.41x
Price / sales
Value assigned to each sales dollar
Reasonable · Between 3x and 8x sales
7.61x
Price / FCF
Price against free cash generation
Rich · Above 35x free cash flow
45.49x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
32.14x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Strong · At least 15% return on capital
17.2%
ROE
Profit generated from shareholder equity
Middle ground · Roughly in line with sector
-
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.07x
Current ratio
Short-term assets against liabilities
No signal · Not enough data to judge
-
Geographic mix
Jun 30, 2026United States57.7% · $3.8B
Europe25.8% · $1.7B
Rest of World10.9% · $712.4M
Japan5.6% · $364.6M
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How EW compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $49.56B | 51.1 | +14.6% | 59 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Edwards Lifesciences (EW) stock
Edwards Lifesciences — US core universe (S&P 500 sourced). EW was +3.2% in the latest available session at $88.83. Its reported market value was $49.56B with a trailing P/E of 51.1. Latest reported revenue was $6.51B, changing +14.6% year over year, with $1.00B in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $88.83
- Day change
- +3.2%
- Market cap
- $49.56B
- P/E (TTM)
- 51.1
- Revenue growth
- +14.6%
- Industry
- Medical Devices